Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2002
10/03/2002US20020143028 For therapy of pain
10/03/2002US20020143026 Induce mitotic arrest thereby making them useful as anti-cancer agents; also for therapy of diseases which can be treated by inducing mitotic arrest
10/03/2002US20020143023 Dihydropyrimidine compounds and compositions containing the same
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020143019 2-aminoalkylaminoquinolines as dopamine D4 ligands
10/03/2002US20020143018 For therapy of animals infected with parasites that cause abortigenic or neurologic diseases, for therapy of parasitic protozoa such as coccidia that cause abortigenic or neurologic diseases of mammals
10/03/2002US20020143016 Administering to a patient suffering from anxiety a therapeutically or prophylactically effective amount of N-desmethylzopiclone, or a pharmaceutically acceptable salt, solvate, hydrate, or clathrate
10/03/2002US20020143014 Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
10/03/2002US20020143012 For imaging amyloid deposits
10/03/2002US20020143008 CRF receptor antagonists and methods relating thereto
10/03/2002US20020143004 Allosteric adenosine receptor modulators
10/03/2002US20020143003 As serotonin, norepinephrine and dopamine reuptake inhibitors, for therapy of central nervous system and other disorders
10/03/2002US20020142985 Therapeutic compositions and methods of treating glycolipid storage related disorders
10/03/2002US20020142983 MUC-1 antagonists and methods of treating immune disorders
10/03/2002US20020142954 Laminin 15 and uses thereof
10/03/2002US20020142950 Methods for enhancing the bioavailability of a drug
10/03/2002US20020142943 A drug and an agent capable of inducing the dephosphorylation of phosphorylated serine and/or threonine residue of p100 and/or p120, wherein the ability of the drug to cross a physiological barrier is improved.
10/03/2002US20020142436 Enzymatic protein for use in the treatment of tumors, nervous system, cardiovascular, psychological, pregnancy, bone, kidney, respiratory and alimentary canal disorders
10/03/2002US20020142392 Human melanocyte stimulating hormone receptor polypeptide and DNA
10/03/2002US20020142372 Fragments of cr1 and their use
10/03/2002US20020142330 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
10/03/2002US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/03/2002US20020142010 Administering neurotoxin
10/03/2002US20020141987 Fish serine proteinases and their pharmaceutical and cosmetic use
10/03/2002US20020141980 Convection-enhanced delivery of AAV vectors
10/03/2002US20020141977 Immunotherapy based on dendritic cells
10/03/2002US20020141971 Administering by tissue absorption
10/03/2002US20020139938 Sensitization of cells with porphyrins, then exposing to radiation and grafting; photodynamic therapy
10/03/2002CA2442178A1 2-amino-propanol derivatives
10/03/2002CA2442003A1 Methods for treating neurodegenerative diseases including alzheimer's
10/03/2002CA2441986A1 Methods and products related to fgf dimerization
10/03/2002CA2441933A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
10/03/2002CA2441926A1 (oxo-pyrazolo[1,5a]pyrimidin-2-yl)alkyl-carboxamides
10/03/2002CA2441889A1 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
10/03/2002CA2441806A1 Inosine compounds and their use for treating or preventing an inflammation or a reperfusion disease
10/03/2002CA2441790A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002CA2441700A1 Polypeptides and nucleic acids for bolekine
10/03/2002CA2441599A1 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain
10/03/2002CA2441455A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
10/03/2002CA2441403A1 Novel agents for ameliorating motor disorder
10/03/2002CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002CA2440713A1 Nicotine-containing oral dosage form
10/03/2002CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002CA2440389A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002CA2440040A1 One-step process for preparing chewing gum
10/03/2002CA2439431A1 Streptococcus pneumoniae proteins and nucleic acids
10/03/2002CA2438206A1 Transporters and ion channels
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002CA2436208A1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor
10/02/2002EP1245565A1 Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them
10/02/2002EP1245562A1 5-THIA-$g(v)-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
10/02/2002EP1245228A2 Medicament for the inducement of cognition enhancement
10/02/2002EP1244916A1 INHIBITION OF $g(b)ARRESTIN MEDIATED EFFECTS PROLONGS AND POTENTIATES OPIOID RECEPTOR-MEDIATED ANALGESIA
10/02/2002EP1244915A2 Method for identifying inhibitors of cytokinesis
10/02/2002EP1244807A1 Il-6 like polynucleotide
10/02/2002EP1244805A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244784A2 Methods and compositions for inhibiting neoplastic cell growth
10/02/2002EP1244780A2 Dna encoding the human serine protease t
10/02/2002EP1244774A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same
10/02/2002EP1244700A2 Vesicle trafficking proteins
10/02/2002EP1244686A1 Transforming growth factor alpha hiii
10/02/2002EP1244685A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244678A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
10/02/2002EP1244677A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
10/02/2002EP1244673A2 Novel imidazo 1,3,5]triazinones and the use thereof
10/02/2002EP1244672A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
10/02/2002EP1244671A1 Triazolo-pyrimidine derivatives as ligands for gaba receptors
10/02/2002EP1244670A1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
10/02/2002EP1244669A1 Pyrazolopyrazines and their use as adenosine antagonists
10/02/2002EP1244667A2 Cyclohexene nucleic acids
10/02/2002EP1244666A1 Imidazopyrimidinyl and imidazopyridinyl derivatives
10/02/2002EP1244663A1 Compounds and methods for the treatment of pain
10/02/2002EP1244662A1 Compound and method for the treatment of pain
10/02/2002EP1244661A1 Compounds and methods for the treatment of pain
10/02/2002EP1244660A1 Methods and compositions for the treatment of pain
10/02/2002EP1244659A1 Pyrazolo-pyridine derivatives as ligands for gaba receptors
10/02/2002EP1244654A1 Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors
10/02/2002EP1244653A1 Non peptide tachykinin receptor antagonists
10/02/2002EP1244649A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244648A1 Chemokine receptor binding heterocyclic compounds
10/02/2002EP1244643A1 Tryptase inhibitors
10/02/2002EP1244641A1 Thiazolyl amide derivatives
10/02/2002EP1244639A1 2-cyclohexyl benzimidazole nmda/nr2b antagonists
10/02/2002EP1244638A2 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents
10/02/2002EP1244632A1 Pyrazole derivatives which modulate human serotonin receptors
10/02/2002EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002EP1244625A1 4-pyridinyl-n-acyl-l-phenylalanines
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002EP1244616A1 (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives
10/02/2002EP1244614A2 Tryptase inhibitors
10/02/2002EP1244498A2 Combination of trimebutine with an opioid analgesic
10/02/2002EP1244466A2 Activation and inhibition of the immune system
10/02/2002EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002EP1244456A1 A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
10/02/2002EP1244454A2 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions
10/02/2002EP1244453A1 Method and composition for the treatment of pain
1 ... 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 ... 1833